Medicare billing address
CMS Medicare provider billing file
925 Chestnut StMezzanine
Philadelphia, PA 19107
CMS public data · NPI 1629091228
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Christopher L Hansen, M.D.
Specialty
Credential
M.D.
NPI
1629091228
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Christopher L Hansen, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
925 Chestnut StCMS Doctors & Clinicians file
925 Chestnut StIn the 2024 CMS provider billing file, this NPI had 2,319 Medicare beneficiaries and 4,663 total services. The average beneficiary age was 72, and the average HCC risk score was 2.4.
Total Medicare allowed amount
$436,489.36
Total Medicare payment amount
$343,676.45
Medicare beneficiaries
2,319
Total services
4,663
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
47%
CMS beneficiary-panel share
Chronic kidney disease
41%
CMS beneficiary-panel share
Mood disorders
40%
CMS beneficiary-panel share
Diabetes
39%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,037 | $8.12 |
| Injection, regadenoson, 0.1 mg | 232 | $11.11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 205 | $20.70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 205 | $13.75 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 151 | $75.45 |
| Nuclear medicine study of heart pumping function with measurement of internal blood volume ejected with every beat over a single cycle | 132 | $168.17 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 131 | $828.78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 128 | $63.98 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 93 | $2,453.91 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 78 | $79.30 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1629091228. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Atorvastatin Calcium | Atorvastatin Calcium | 105 | 300 | $1,473.87 |
| 2 | Metoprolol Succinate | Metoprolol Succinate | 74 | 192.6 | $1,186.71 |
| 3 | Amlodipine Besylate | Amlodipine Besylate | 47 | 138.7 | $467.14 |
| 4 | Eliquis | Apixaban | 36 | 80 | $45,522.24 |
| 5 | Metoprolol Tartrate | Metoprolol Tartrate | 31 | 93 | $434.59 |
| 6 | Furosemide | Furosemide | 29 | 83 | $154.64 |
| 7 | Lisinopril | Lisinopril | 23 | 69 | $81.80 |
| 8 | Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | 63 | $558.27 |
| 9 | Rosuvastatin Calcium | Rosuvastatin Calcium | 19 | 57 | $286.41 |
| 10 | Warfarin Sodium | Warfarin Sodium | 19 | 57 | $240.86 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Temple University School Of Medicine
Graduation year
1981
Group/practice field
Jefferson University Physicians
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.